Hirtle Callaghan & Co’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Hirtle Callaghan & Co’s Portfolio COV Stock Details COV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,700	Closed	-$583K	–	488
2014 Q4	$583K	Hold	5,700	–	–	0.14%	98
2014 Q3	$493K	Sell	5,700 -1,238	-18%	-$110K	0.08%	108
2014 Q2	$626K	Hold	6,938	–	–	0.09%	127
2014 Q1	$511K	Hold	6,938	–	–	0.08%	126
2013 Q4	$472K	Hold	6,938	–	–	0.06%	137
2013 Q3	$423K	Buy	+6,938	New	+$423K	0.07%	143

Hirtle Callaghan & Co's COV Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q1 2015, closing a stake of 5,700 shares — an estimated $583K sold.

Hirtle Callaghan & Co first reported a position in COV in Q3 2013 and held it in 6 quarters. The position peaked at $626K in Q2 2014. 1 fund tracked by Wall St. Rank holds COV as of Q1 2015.

Hirtle Callaghan & Co reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q1 2015 after selling out during the quarter.
Hirtle Callaghan & Co sold 5,700 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q1 2015, an estimated $583K.
Hirtle Callaghan & Co first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2013 and held it in 6 quarters.
Hirtle Callaghan & Co's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $626K in Q2 2014.
1 fund tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.